Preliminary Program

Sessions requiring tickets are noted throughout the 2017 ASCO Annual Meeting Preliminary Program ( = Ticketed Session). Learn more about adding the Ticketed Session package to your registration.

The Preliminary Program is current as of February 08, 2017. Discover more information on the different session types at the 2017 ASCO Annual Meeting.

7:30 AM–9:15 AM

Highlights of the Day Session

Highlights of the Day Session I

7:30 AM–9:30 AM

Education Session

Training Program Directors' Breakfast (Training Program Directors and Associate Training Program Directors Only)

Michael P. Kosty, MD, FACP

Scripps Research Institute

Current Programs and Resources for Training Programs

Sarbajit Mukherjee, MD

University of Oklahoma Health Sciences Center

ASCO University’s Education Essentials for Oncology Fellows

Claire Lenee Hiles, MD

San Antonio Uniformed Services Health Education Consortium

New Initiatives: FDA and ASCO Fellow's Day Workshop

Helen K. Chew, MD

University of California Davis Medical Center

New Initiatives: Resiliency Skills Training

Mamta Parikh, MD

University of California, Davis

New Initiatives: Resiliency Skills Training

Francis P. Worden, MD—Chair

University of Michigan Comprehensive Cancer Center 

Innovative Ways to Stay Connected and Network

8:00 AM–9:15 AM


Education Sessions

Enhancing Survivorship for Women With Gynecologic Cancer

Donald L. Rosenstein, MD, MPH—Chair

The University of North Carolina at Chapel Hill

Psycho-Oncology and the Cancer Survivor

David M. Kushner, MD

University of Wisconsin

Enhancing and Restoring Sexuality After Surviving Cancer

Carmina G. Valle, PhD, MPH

University of North Carolina at Chapel Hill

Enhancing Benefits of Exercise for the Survivor Using Emerging Technology


Guidelines and Pathways for the Practicing Oncologist 

Robin Zon, MD, FACP, FASCO—Chair

Michiana Hematology Oncology, PC

Evolution of Pathways

Peter G. Ellis, MD 

University of Pittsburgh Medical Center

Implementation of Pathways and Guidelines in Oncology

Anne C. Chiang, MD, PhD

Yale Cancer Center 

Using Guidelines to Deliver Precision Cancer Care


Is the Sharper Knife Worth the Price? A Discussion of Protons Versus Photons

Sue Sun Yom, MD, PhD—Chair 

University of California, San Francisco  

Nancy Y. Lee, MD

Memorial Sloan Kettering Cancer Center

David M. Brizel, MD

Duke University Medical Center


Starting the Conversation: Interventions to Reduce Financial Toxicity

Yousuf Zafar, MD, MHS—Chair

Duke University Medical Center

Overview of Financial Toxicity

Alex Bastian, MBA


Industry Perspective

Lee N. Newcomer, MD

UnitedHealth Group

Payer Perspective on Patient Out-of-Pocket Costs

Shelley Fuld Nasso, MPP

National Coalition for Cancer Survivorship

Patient Perspective

Leonard Saltz, MD

Memorial Sloan Kettering Cancer Center

Drug Pricing and Oncology Practice


Strategies to Maximize Patient Participation in Clinical Trials

Julia A. Beaver, MD—Chair 

U.S. Food and Drug Administration 

Modernizing Eligibility Criteria for Clinical Trials: ASCO-FDA-FOCR Perspective

Eric H. Rubin, MD

Merck Research Laboratories

Implementation of Modern Eligibility in Trials: Industry Perspective

Mary Jackson Scroggins, MA

Pinkie Hugs

Improving Access to Clinical Trials: Patient Perspective


Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice

Elaine S. Jaffe, MD

The National Cancer Institute's Center for Cancer Research

Understanding the New WHO Classification for Lymphoid Malignancies

Paul M. Barr, MD

Wilmot Cancer Institute, University of Rochester Medicine

Application of WHO Classifications for Lymphoid Malignancies on Clinical Practice

Sonali M. Smith, MD—Chair

University of Chicago

The Impact of WHO Lymphoid Malignancy Changes on Clinical Trials Moving Forward


Meet the Professor Session

Ticketed SessionNew Approaches for Older Adults: Individualized Management of Aggressive 


Clinical Problems in Oncology Session

Ticketed SessionTreating Special Populations of Patients With Leukemia and Myelodysplastic Syndromes

Patrick A. Brown, MD

The Sidney Kimmel Comprehensive Cancer Center

Considerations in Children and Young Adults With Acute Leukemia

Jane Apperley, MBChB, MD, FRCP, FRCPath—Chair

Imperial College London

Managing Fertility, Pregnancy, and Family Planning in Leukemia

Gert J.Ossenkoppele M.D. PhD

VU University Medical Center​

Guiding Elderly Patients With Leukemia and Myelodysplastic Syndrome Through Therapy

8:00 AM–9:30 AM

Clinical Science Symposium

Lung Cancer

8:00 AM–11:00 AM


Oral Abstract Sessions

Central Nervous System Tumors
Gastrointestinal (Noncolorectal) Cancer
Melanoma/Skin Cancers
Tumor Biology

8:00 AM–11:30 AM

Poster Sessions

Breast Cancer—Local/Regional/Adjuvant

Breast Cancer—Metastatic

Genitourinary (Nonprostate) Cancer

Pediatric Oncology


9:45 AM–11:00 AM

Education Sessions

Business of Practice 2017: New Rules, New Strategies

Ray D. Page, DO, PhD, FACOI

The Center for Cancer and Blood Disorders

The Oncology Medical Home: Why Is It Important?

Michael P. Kosty, MD, FACP

Scripps Research Institute

Utilizing Teams in a Changing Practice Environment

Stephen Grubbs, MD

American Society of Clinical Oncology

Strategies to Maximize Your MIPS Success


Immunotherapy for Gynecologic Cancers: A New Treatment Standard?

Hans Nijman, MD, PhD

University Medical Center Groningen

Waking the Immune System Therapeutically in Endometrial Cancers

Samir Khleif, MD—Chair

Georgia Cancer Center, Augusta University

Immuno Checkpoint Therapy Combinations with PARP or with Other Checkpoint Inhibitors in Ovarian Cancer

Mark H. Einstein, MD

Albert Einstein College of Medicine

New Vaccine Approaches for the Treatment of Cervical Cancer


Is Tissue Still the Issue? Pathology Issues in Thoracic Oncology

David R. Spigel, MD

Sarah Cannon Research Institute

Too Much Information: Separating the Wheat From the Chaff in Next-Generation Sequencing Reports and How to Use Them in Clinical Practice

Alice Tsang Shaw, MD, PhD—Chair

Massachusetts General Hospital

How to Incorporate Liquid Biopsies Into Practice: A Molecular Maven's View

Jhanelle Elaine Gray, MD

H. Lee Moffitt Cancer Center and Research Institute

Challenges in Thoracic Pathology: How I Approach Mixed Histologies and Differentiating Metastasis in the Chest From Second Primaries


Patient Communication: Balancing Hope Versus Reality

Anthony Back, MD—Chair

Seattle Cancer Care Alliance

Transitioning Hope While Moving From Treatment to Supportive Care

Gary E. Deng, MD, PhD

Memorial Sloan Kettering Cancer Center

Partnering With Patients Who Embrace Nontraditional Cancer Treatment

James F. Cleary, MD

University of Wisconsin School of Medicine and Public Health

Discussing Goals of Care When Cancer Is Chronic


Risk-Adapted Screening for Breast, Ovarian, and Gastrointestinal Cancers: Advances and Controversies

Marian Mourits, MD, PhD

University Medical Center Groningen

Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population in Europe and the United States

Noah D. Kauff, MD

Memorial Sloan Kettering Cancer Center

European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population

Mark Helvie, MD

University of Michigan

Pros and Cons of Breast Imaging Technologies for Individuals at Elevated Risk


Therapeutic Bone-Modifying Agents in the Nonmetastatic Setting

Michael Gnant, MD, FACS

Medical University of Vienna

Pro: Therapeutic Bone-Modifying Agents

Catherine H. Van Poznak, MD

University of Michigan Comprehensive Cancer Center

Con: Therapeutic Bone-Modifying Agents

Lowell E. Schnipper, MD, PhD—Chair

Beth Israel Deaconess Medical Center

Value Discussion and Moderator


Meet the Professor Session

Ticketed SessionGermline Testing in Prostate Cancer

Kathleen A. Cooney, MD

University of Utah

Germline Testing in Prostate Cancer and Questions About Prevention

Peter Nelson, MD

Fred Hutchinson Cancer Research Center

Germline Genetic Testing in Men with Prostate Cancer: Who to Test and What to Do with the Results?


Clinical Problems in Oncology Session

Ticketed SessionDysphagia: Why Can't Patients Swallow?

Giselle Carnaby, PhD, MPH, CCC-SLP

University of Central Florida

Survivorship and the Rehabilitation of Patients With Swallowing Disorders 

Maggie Kuhn, MD—Chair

University of California, Davis

Dysphagia: Why Can't Patients Eat? A Case-Based Discussion

Miriam Lango, MD

Fox Chase Cancer Center

Evaluation of Swallowing Prior to Initiation of Therapy

9:45 AM–11:15 AM

Clinical Science Symposium

Special Clinical Science Symposium

9:45 AM–12:45 PM

Oral Abstract Sessions

Hematologic Malignancies—Plasma Cell Dyscrasia

11:30 AM–12:45 PM

Poster Discussion Sessions

Breast Cancer—Local/Regional/Adjuvant

Genitourinary (Nonprostate) Cancer

Pediatric Oncology


Education Sessions

Bench-to-Bedside Approaches for Personalized Exercise Interventions for Cancer Survivors

Lee Jones, PhD—Chair 

Memorial Sloan Kettering Cancer Center

A Bench-to-Bedside Approach to Personalizing Exercise Interventions to Reduce Recurrence

Jessica Scott, PhD

Johnson Space Center

Using Basic Science to Personalize Exercise Interventions to Prevent Cardiovascular Disease in Patients With Cancer

Neil Derek Eves, PhD

The University of British Columbia

Using Basic Science to Understand Risk and Personalize Interventions for Cancer-Related Fatigue


Best Practices and Practical Nuances in the Treatment of Gastric Cancer in High-Risk Global Areas

Federico Augusto Sanchez, MD—Chair

Aurora Advanced Healthcare

Unique Features of Gastric Cancer in Central and South America: Treatment and Value?

Ramon Andrade De Mello, MD, PhD

University of Algarve

Gastric Cancer in Southern Europe: High-Risk Disease

Yuko Kitagawa, MD, PhD, FACS

Keio University School of Medicine

Gastric Cancer in Asia: Unique Features and Management


Clinically Relevant Advances in Central Nervous System Tumors: Year in Review

Matthias Preusser, MD—Chair

Medical University of Vienna

Takeaways from the European Association of Neuro-Oncology Meeting

Marta Penas-Prado, MD

The University of Texas MD Anderson Cancer Center

Practice-Changing Abstracts in 2016 From the Society for Neuro-Oncology

Samuel T. Chao, MD

The Cleveland Clinic

Central Nervous System Tumor Highlights From the American Society for Radiation Oncology Meeting


Incorporating Precision Medicine Into Your Practice: How, Why, and When?

Edward S. Kim, MD

Levine Cancer Institute-Carolinas HealthCare System

Non-Small Cell Lung Cancer as the Paradigm for Precision Oncology

Lee Steven Schwartzberg, MD—Chair

University of Tennessee Health Science Center

Navigating the Maze of Molecular Testing to Achieve Actionable Results

Deborah Schrag, MD, MPH

Dana-Farber Cancer Institute

Aligning Value and Precision Medicine


Tumor and Clinical Heterogeneity

Barry S. Taylor, PhD

Memorial Sloan Kettering Cancer Center

Evolutionary Biology in the Treatment of Cancer

Joel W. Neal, MD, PhD

Cancer Institute, Stanford Medicine

Impact of Heterogeneity and Biomarkers

Wafik S. El-Deiry, MD, PhD—Chair

Fox Chase Cancer Center

Emerging Complexity of Tumor Heterogeneity and Clinical Practice


Using Social Media and Mobile Technology for Cancer Prevention and Treatment

Judith Prochaska, PhD, MPH—Chair

Stanford Prevention Research Center, Stanford Medicine

Social Media and Smoking Cessation

Steven S. Coughlin, PhD

University of Massachusetts

Privacy Concerns with Social Media (HIPAA Compliance): Answering Your Patients' Questions

Elizabeth Lyons, PhD, MPH

The University of Texas Medical Branch

Using Social Media in Resource-Poor Settings to Enhance Prevention and Treatment Adherence


Meet the Professor Sessions

Ticketed SessionDevelopmental Therapeutics in Older Adults With Cancer

Mark J. Ratain, MD

The University of Chicago


Ticketed SessionUpdates in the Treatment of Neuroendocrine and Hepatobiliary Cancers

Mitesh J. Borad, MD

Mayo Clinic

Novel Therapies in Hepatobiliary Carcinoma

Diane Lauren Reidy, MD

Weill Cornell Medical College

Emerging Therapies in Neuroendocrine Cancers

12:15 PM–12:45 PM


Education Session

Physician Wellness: Refresh and Reboot at the Annual Meeting 

Anthony Back, MD

Seattle Cancer Care Alliance

1:00 PM–4:00 PM

Plenary Session

Plenary Session Including the Science of Oncology Award and Lecture

4:00 PM–4:30 PM

Post-Plenary Session

Post-Plenary Discussion Session I

4:30 PM–5:00 PM

Post-Plenary Session

Post-Plenary Discussion Session II

4:45 PM–6:00 PM

Poster Discussion Sessions

Breast Cancer—Metastatic



Education Sessions

Adoptive T-Cell Therapy: Ready for Prime Time?

Renier J. Brentjens, MD, PhD — Chair

Memorial Sloan Kettering Cancer Center 

Adoptive T-Cell Therapy for Solid Tumors in 2017

Cassian Yee, MD

The University of Texas MD Anderson Cancer Center

Antigen Selection in T-Cell Therapy

Carl H. June, MD

Abramson Cancer Center at Penn Medicine

Synthetic Immunology in Oncology


Career Management: Mentorship in the Community Setting

Kelly J. Cooke, DO—Chair

ProHealth Care

Mentorship: Getting Started

Debra A. Patt, MD, MPH, MBA

McKesson Specialty Health–The US Oncology Network

Tenets of Being a Good Mentor

Roshan Sudhir Prabhu, MD, MS

Southeast Radiation Oncology Group, PA

Mentee Experience: Assessing Needs, Asking, and Maintaining the Relationship


Immunotherapy in Multiple Myeloma

Madhav V. Dhodapkar, MBBS

Yale University

Overview of the Immune System in Plasma Cell Disorders

Ivan Borrello, MD

Johns Hopkins University

Monoclonal and Bi-specific Antibodies (Bites) for Myeloma: Nipping at a Cure

Edward Allen Stadtmauer, MD—Chair

Abramson Cancer Center at Penn Medicine 

Cars and Beyond: Cellular Immunotherapies in Myeloma


It's More Than Chest Radiation: Breast Cancer Risk, Prevention, and Surveillance After Childhood, Adolescent, and Young Adult Cancer

David C. Hodgson, MD, MPH

Princess Margaret Cancer Centre

Breast Cancer Risk After Modern Cancer Treatment: Modeling to Derive Risk

Flora Van Leeuwen, PhD

The Netherlands Cancer Institute

Roles of Chemotherapy, Gonadal Hormones, and Genetic Factors Influencing Risk of Breast Cancer in Adolescents and Young Adults

Tara O. Henderson, MD, MPH—Chair

The University of Chicago

Surveillance, Prevention, and Screening for Breast Cancer in Survivors of Childhood, Adolescent, and Young Adult Cancer


Liquid and Solid Biopsies of Metastatic Lesions: How, When, and What to Do With the Results?

Himisha Beltran, MD

Weill Cornell Medical College

Selection, Timing, and Interpretation of Metastatic Castration-Resistant Prostate Cancer Lesions

Terence W. Friedlander, MD—Chair

University of California San Francisco Medical Center

Liquid Biopsies: Current Utility and Future Directions

Colin Pritchard, MD, PhD

University of Washington

Challenges in Translating Molecular Results Into Meaningful Clinical Use


Tobacco Cessation and CT Screening Recommendations for Patients With Lung Cancer

Irina Veytsman, MD

PinnacleHealth Cancer Center

How to Develop a Smoking Cessation Program: A Real-World Guide to Implementation and Evaluation

Peter J. Mazzone, MD, MPH

Cleveland Clinic

A Guide to Developing a Lung Cancer Screening Program in Your Area

Christopher S. Lathan, MD, MS, MPH—Chair

Dana-Farber Cancer Institute

Disparities in Lung Cancer Screening Utilization: Effective Outreach to the Community


Turning the On-Off Dial: Cancer Epigenetics and Therapy

Eliezer Mendel Van Allen, MD—Chair

Dana-Farber Cancer Institute

Epigenetic Therapy: Integrating With Genetics

Jean-Pierre J. Issa, MD

Temple University

Cancer Epigenetics and Therapy: To Turn On or Off?

Yogen Saunthararajah, MD

University of Illinois at Chicago

Higher-Level Pathway Objectives of Epigenetic Therapy: A Solution to the p53 Problem in Cancer?


Using the New ASCO Clinical Practice Guideline for Palliative Care

Thomas J. Smith, MD, FACP, FASCO, FAAHPM—Chair

Johns Hopkins Medicine

A TEAM Approach to the Palliative Care Guideline

Cardinale B. Smith, MD

Icahn School of Medicine at Mount Sinai

The Evidence to Support the New Palliative Care Guidelines


Meet the Professor Sessions

Ticketed SessionIncorporating Clinical Informatics Into Your Practice

Peter Paul Yu, MD, FACP, FASCO

Hartford HealthCare Cancer Institute

Incorporating Clinical Informatics Into Your Practice


Ticketed SessionPerspectives on Oncology Careers in Global Health

Yun Yen, MD, PhD

Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University

Academic Careers Across the Pacific

Nagi S. El Saghir, MD, FACP

American University of Beirut

National Oncology Societies

5:00 PM–5:30 PM

Post-Plenary Session

Post-Plenary Discussion Session III

5:30 PM–6:00 PM

Post-Plenary Session

Post-Plenary Discussion Session IV